Sherbrooke Park Advisers’s Humana HUM Stock Holding History

Sherbrooke Park Advisers’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,036	Closed	-$474K	–	913
2023 Q4	$474K	Sell	1,036 -2,600	-72%	-$1.28M	0.22%	172
2023 Q3	$1.77M	Buy	+3,636	New	+$1.71M	0.56%	22
2023 Q1	–	Sell	-1,100	Closed	-$563K	–	248
2022 Q4	$563K	Buy	+1,100	New	+$578K	0.41%	96

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Sherbrooke Park Advisers's HUM Position: Q1 2024 in Review

Sherbrooke Park Advisers sold out of Humana (HUM) in Q1 2024, closing a stake of 1,036 shares — an estimated $474K sold.

Sherbrooke Park Advisers first reported a position in HUM in Q4 2022 and held it in 3 quarters. The position peaked at $1.77M in Q3 2023. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

Sherbrooke Park Advisers reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
Sherbrooke Park Advisers sold 1,036 Humana shares in Q1 2024, an estimated $474K.
Sherbrooke Park Advisers first reported a position in Humana in Q4 2022 and held it in 3 quarters.
Sherbrooke Park Advisers's Humana position peaked at $1.77M in Q3 2023.
1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.